References
- A.M. Api, D. Belsito, D. Botelho, M. Bruze, G.A. Burton Jr., J. Buschmann, M.L. Dagli, M. Date, W. Dekant, C. Deodhar, M. Francis, A.D. Fryer, L. Jones, K. Joshi, S. La Cava, A. Lapczynski, D.C. Liebler, D. O’Brien, A. Patel, T.M. Penning, G. Ritacco, J. Romine, N. Sadekar, D. Salvito, T.W. Schultz, I.G. Sipes, G. Sullivan, Y. Thakkar, Y. Tokura, and S. Tsang, RIFM fragrance ingredient safety assessment, 2-phenoxyethanol, CAS registry number 122-99-6, Food Chem. Toxicol. 130 (2019), pp. 110629. doi:https://doi.org/10.1016/j.fct.2019.110629.
- A. Hartwig, 2‐Phenoxyethanol-MAK Value Documentation, 2017, (2019), doi:https://doi.org/10.1002/3527600418.mb12299kske6319.
- J.A. Troutman, D.L. Rick, S.B. Stuard, J. Fisher, and M.J. Bartels, Development of a physiologically-based pharmacokinetic model of 2-phenoxyethanol and its metabolite phenoxyacetic acid in rats and humans to address toxicokinetic uncertainty in risk assessment, Regul. Toxicol. Pharmacol. 73 (2015), pp. 530–543. doi:https://doi.org/10.1016/j.yrtph.2015.07.012.
- T.H. Kim, M.G. Kim, M.G. Kim, B.S. Shin, K.B. Kim, J.B. Lee, S.H. Paik, and S.D. Yoo, Simultaneous determination of phenoxyethanol and its major metabolite, phenoxyacetic acid, in rat biological matrices by LC-MS/MS with polarity switching: Application to ADME studies, Talanta 144 (2015), pp. 29–38. doi:https://doi.org/10.1016/j.talanta.2015.05.075.
- B. Dreno, T. Zuberbier, C. Gelmetti, G. Gontijo, and M. Marinovich, Safety review of phenoxyethanol when used as a preservative in cosmetics, J. Eur. Acad. Dermatol. Venereol. 33 (2019), pp. 15–24. doi:https://doi.org/10.1111/jdv.15944.
- S.C.o.C.S. (SCCS), Request for a scientific opinion for the use of phenoxyethanol (CASn.122-99-6) as preservative, (2013). Available at http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_q_093.pdf
- J. Louisse, E. de Jong, J.J. van de Sandt, B.J. Blaauboer, R.A. Woutersen, A.H. Piersma, I.M. Rietjens, and M. Verwei, The use of in vitro toxicity data and physiologically based kinetic modeling to predict dose-response curves for in vivo developmental toxicity of glycol ethers in rat and man, Toxicol. Sci. 118 (2010), pp. 470–484. doi:https://doi.org/10.1093/toxsci/kfq270.
- S.C.o.C.S. (SCCS), Opinion on Phenoxyethanol, The SCCS adopted opinion at its 2nd plenary meeting (2016). European Commission, Health and Food Safety, L-2920, Luxembourg.
- S.M. Hays, B.A. Elswick, G.M. Blumenthal, F. Welsch, R.B. Conolly, and M.L. Gargas, Development of a physiologically based pharmacokinetic model of 2-methoxyethanol and 2-methoxyacetic acid disposition in pregnant rats, Toxicol. Appl. Pharmacol. 163 (2000), pp. 67–74. doi:https://doi.org/10.1006/taap.1999.8836.
- M. Kwon, J.B. Park, M. Kwon, J. Song, C.S. Yeo, and S.H. Bae, Pharmacokinetics of 2-phenoxyethanol and its major metabolite, phenoxyacetic acid, after dermal and inhaled routes of exposure: Application to development PBPK model in rats, Arch. Toxicol. 95 (2021), pp. 2019–2036. doi:https://doi.org/10.1007/s00204-021-03041-z.
- D. Howes, Absorption and metabolism of 2-phenoxyethanol in rat and man, 15th IFSCC Int. Congr. Cosmet. Sci. 3 (1991), pp. 415–434.
- R. Ben-Dyke, R. Ashby, A. Bhatt, and A.J. Newman, Phenoxyethanol: Toxicity in oral administration to rats for thirteen weeks., from COLIPA, 1980. Summaries of Submissions I and II on Phenoxyethanol. COLIPA report no. 77/NLL5/375 (1977).
- M. J, Japan industrial safety and health association drinking water 13-week study of 2-phenoxyethanol in F344 rats, Japan Bioassay Res. Center, Study No. 0459, 2003.
- A.T. McCoy, M.J. Bartels, D.L. Rick, and S.A. Saghir, TK modeler version 1.0, a Microsoft(R) Excel(R)-based modeling software for the prediction of diurnal blood/plasma concentration for toxicokinetic use, Regul. Toxicol. Pharmacol. 63 (2012), pp. 333–343. doi:https://doi.org/10.1016/j.yrtph.2012.04.002.